In the News

Herbal capsule may lower risk of developing type 2 diabetes in prediabetes patients

Patients with impaired glucose tolerance who were treated with Chinese herbs for a year were significantly less likely to develop diabetes than matched patients who didn't take the herbs, a study found.

No ‘obesity paradox’ for mortality found in diabetics

A new study found no evidence of a mortality benefit for diabetics in being obese or overweight and thus did not support the so-called “obesity paradox.”

Spousal diabetes associated with personal increase in diabetes risk

Having a spouse with diabetes was associated with a 26% increase in personal diabetes risk, according to a recent study.

MKSAP Quiz: type 1 diabetic with hyperglycemia after exercise

This month's quiz asks readers to evaluate a 32-year-old man with type 1 diabetes and significant blood glucose elevations associated with exercise.

Intensive BP and cholesterol treatment didn't affect cognitive decline after 40 months

In patients with type 2 diabetes, intensive control of blood pressure and cholesterol did not protect against cognitive decline, a recent study found.

Review: Bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment

A meta-analysis of 11 randomized, controlled trials found that bariatric surgery improved several health and diabetes outcomes more than nonsurgical treatment.

Safety of dipeptidyl peptidase-4 inhibitors analyzed in 2 studies

A meta-analysis of dipeptidyl peptidase-4 inhibitors showed no increase in pancreatic adverse events, while a trial of saxagliptin found no effect on the overall rate of cardiovascular events.

Saxagliptin under analysis for heart failure risk

The FDA has requested clinical trial data on saxagliptin (Onglyza and Kombiglyze XR) to investigate a possible increase in heart failure in patients taking the drug.

Test strips recalled

Twenty lots of Abbott's FreeStyle and FreeStyle Lite blood glucose test strips were recalled.

Spotlight on new diabetes technologies

Technological advances that could improve diabetes control in the future made the news in the past month.